[HTML][HTML] Trypanosoma cruzi Infection and Endothelin-1 Cooperatively Activate Pathogenic Inflammatory Pathways in Cardiomyocytes

RS Corral, NA Guerrero, H Cuervo… - PLoS neglected …, 2013 - journals.plos.org
RS Corral, NA Guerrero, H Cuervo, N Gironès, M Fresno
PLoS neglected tropical diseases, 2013journals.plos.org
Trypanosoma cruzi, the causative agent of Chagas' disease, induces multiple responses in
the heart, a critical organ of infection and pathology in the host. Among diverse factors,
eicosanoids and the vasoactive peptide endothelin-1 (ET-1) have been implicated in the
pathogenesis of chronic chagasic cardiomyopathy. In the present study, we found that T.
cruzi infection in mice induces myocardial gene expression of cyclooxygenase-2 (Cox2) and
thromboxane synthase (Tbxas1) as well as endothelin-1 (Edn1) and atrial natriuretic peptide …
Trypanosoma cruzi, the causative agent of Chagas' disease, induces multiple responses in the heart, a critical organ of infection and pathology in the host. Among diverse factors, eicosanoids and the vasoactive peptide endothelin-1 (ET-1) have been implicated in the pathogenesis of chronic chagasic cardiomyopathy. In the present study, we found that T. cruzi infection in mice induces myocardial gene expression of cyclooxygenase-2 (Cox2) and thromboxane synthase (Tbxas1) as well as endothelin-1 (Edn1) and atrial natriuretic peptide (Nppa). T. cruzi infection and ET-1 cooperatively activated the Ca2+/calcineurin (Cn)/nuclear factor of activated T cells (NFAT) signaling pathway in atrial myocytes, leading to COX-2 protein expression and increased eicosanoid (prostaglandins E2 and F, thromboxane A2) release. Moreover, T. cruzi infection of ET-1-stimulated cardiomyocytes resulted in significantly enhanced production of atrial natriuretic peptide (ANP), a prognostic marker for impairment in cardiac function of chagasic patients. Our findings support an important role for the Ca2+/Cn/NFAT cascade in T. cruzi-mediated myocardial production of inflammatory mediators and may help define novel therapeutic targets.
PLOS